SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001589045-13-000001
Filing Date
2013-10-11
Accepted
2013-10-11 11:10:46
Documents
1
Period of Report
2013-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1451
  Complete submission text file 0001589045-13-000001.txt   2989
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005 3146456600
K-V Pharmaceutical Co (Issuer) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUSQUEHANNA ADVISORS GROUP, INC. 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address
Nielson Steven (Reporting) CIK: 0001589045 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09601 | Film No.: 131147236